EMA grants Orphan Drug Designation for Setmelanotide for treatment of acquired hypothalamic obesityThe European Medicines Agency (EMA) has issued a positive opinion on the Rhythm Pharmaceuticals’ orphan drug designation request for...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment3 days ago